This study augments current understanding of the vascular networks supporting the bone matrix of a sample of bats (n = 24) of variable body mass, representing three families (Pteropodidae [large-bodied, species = 6], Phyllostomidae [medium-bodied, species = 2], and Molossidae [medium-bodied, species = 1]).
Bats are the only mammals to have achieved powered flight. A key innovation allowing for bats to conquer the skies was a forelimb modified into a flexible wing. The wing bones of bats are exceptionally long and dynamically bend with wingbeats. Bone microarchitectural features supporting these novel performance attributes are still largely unknown. The humeri and femora of bats are typically avascular, except for large-bodied taxa (e.g., pteropodid flying foxes). No thorough investigation of vascular canal regionalization and morphology has been undertaken, since historically it has been difficult to reconstruct the 3D architecture of these canals. The current study employed Synchrotron Radiation-based micro-Computed Tomography (SRμCT) to enable a detailed comparison of canal morphology within humeri and femora. Results indicate that across selected bats, canal number per unit volume is similar independent of body size. Differences in canal morphometry based on body size and bone type appear primarily related to a broader distribution of the canal network as cortical volume increases. Heavier bats display a relatively rich vascular network of mostly longitudinally oriented canals that are localized mainly to the mid-cortical and endosteal bone envelopes. Taken together, the study’s results suggest that relative vascularity of the limb bones of heavier bats forms support for nutrient exchange in a regional pattern. (publisher abstract modified)
Downloads
Similar Publications
- Sex Estimation Using Metrics of the Innominate: A Test of the DSP2 Method
- Analyzing and interpreting deoxyribonucleic acid from multiple donors using a forensically relevant single-cell strategy
- In Vitro Structure-activity Relationships and Forensic Case Series of Emerging 2-benzylbenzimidazole 'Nitazene' Opioids